An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

Journal: Nature Communications

Published: 2020-08-06

DOI: 10.1038/s41467-020-17673-9

Affiliations: 107

Authors: 126

Go to article
Institutions Share
NIH National Cancer Institute (NCI), United States of America (USA) 0.12
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.08
University of Southern California (USC), United States of America (USA) 0.06
Karolinska Institute (KI), Sweden 0.04
University of Oxford, United Kingdom (UK) 0.03
Harvard University, United States of America (USA) 0.03
American Cancer Society (ACS), United States of America (USA) 0.03
University of Cambridge, United Kingdom (UK) 0.03
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.03
The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.03
Imperial College London (ICL), United Kingdom (UK) 0.02
Brigham and Women's Hospital (BWH), United States of America (USA) 0.02
University of Hawai'i at Manoa (UH Mānoa), United States of America (USA) 0.02
Oslo University Hospital (OUS), Norway 0.02
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA) 0.02
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.02
University of Bristol (UoB), United Kingdom (UK) 0.02
Erasmus University Medical Center (Erasmus MC), Netherlands 0.02
Manchester NIHR Biomedical Research Centre (Manchester BRC), United Kingdom (UK) 0.01
Australian Prostate Cancer Research Centre - Queensland (APCRC - Q), Australia 0.01
Ulm University Medical Center, Germany 0.01
Genomix Inc., United States of America (USA) 0.01
John Radcliffe Hospital, United Kingdom (UK) 0.01
Princess Margaret Cancer Centre, U of T, Canada 0.01
Translational Research Institute (TRI), Australia 0.01
Florida State University (FSU), United States of America (USA) 0.01
International Hereditary Cancer Center (IHCC), PMU, Poland 0.01
Ghent University (UGent), Belgium 0.01
The University of Texas MD Anderson Cancer Center, United States of America (USA) 0.01
Beckman Research Institute, City of Hope, United States of America (USA) 0.01
University of Malaya (UM), Malaysia 0.01
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.01
Medical University of Sofia, Bulgaria 0.01
Biomedical Sciences Group, KU Leuven, Belgium 0.01
Centre for Research in Epidemiology and Population Health (CESP), France 0.01
University of Surrey, United Kingdom (UK) 0.01
Mayo Clinic's Campus in Florida, United States of America (USA) 0.01
Addenbrooke's Hospital, United Kingdom (UK) 0.01
Queen Mary University of London (QMUL), United Kingdom (UK) 0.01
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.01
Stanford University, United States of America (USA) 0.01
The University of Melbourne (UniMelb), Australia 0.01
UH Seidman Cancer Center, CWRU, United States of America (USA) 0.01
Case Western Reserve University (CWRU), United States of America (USA) 0.01
Cancer Epidemiology Division (CED), Cancer Council Victoria, Australia 0.01
The Christie NHS Foundation Trust, United Kingdom (UK) 0.01
University of Washington (UW), United States of America (USA) 0.01
Stanford Medicine, United States of America (USA) 0.01
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.01
Alberta Health Services (AHS), Canada 0.01
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.01
Queensland University of Technology (QUT), Australia 0.01
German Consortium of Translational Cancer Research (DKTK), Germany 0.01
University of Porto (UP), Portugal 0
Portuguese Oncology Institute (IPO), Portugal 0
George E. Wahlen Department of VA Medical Center, United States of America (USA) 0
The University of Warwick (Warwick), United Kingdom (UK) 0
The University of Manchester (UoM), United Kingdom (UK) 0
Health Sciences Center (HSC), Utah, United States of America (USA) 0
GRC 5: Oncotype-URO, France 0
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0
UW Medicine, United States of America (USA) 0
Centre for Research on Prostatic Diseases (CeRePP), France 0
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0
Aarhus University Hospital, Denmark 0
Aarhus University (AU), Denmark 0
University of Turku (UTU), Finland 0
Uppsala University (UU), Sweden 0
UCL, United Kingdom (UK) 0
Turku University Hospital (TYKS), UTU, Finland 0
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0
SWOG Statistics and Data Management Center, United States of America (USA) 0
University of Alberta (U of A), Canada 0
Genomic Medicine Group (GMX), Spain 0
Galician Foundation of Genomic Medicine (FPGMX), Spain 0
UC San Diego Health System, United States of America (USA) 0
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0
USC Health Research Institute of Santiago de Compostela (IDIS), Spain 0
Longyan University, China 0
USC University Hospital Complex (CHUS), Spain 0
International Epidemiology Institute (IEI), United States of America (USA) 0
Gentofte University Hospital, Denmark 0
Herlev University Hospital, Denmark 0
Centre for Research in Environmental Epidemiology (CREAL), ISGlobal, Spain 0
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0
Hospital del Mar Medical Research Institute (IMIM), Spain 0
Pompeu Fabra University (UPF), Spain 0
University of Copenhagen (UCPH), Denmark 0
Copenhagen University Hospital (CUH), Denmark 0

Return